Correlation Between Integrated Biopharma and National American
Can any of the company-specific risk be diversified away by investing in both Integrated Biopharma and National American at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Integrated Biopharma and National American into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Integrated Biopharma and National American University, you can compare the effects of market volatilities on Integrated Biopharma and National American and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Integrated Biopharma with a short position of National American. Check out your portfolio center. Please also check ongoing floating volatility patterns of Integrated Biopharma and National American.
Diversification Opportunities for Integrated Biopharma and National American
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Integrated and National is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Integrated Biopharma and National American University in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on National American and Integrated Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Integrated Biopharma are associated (or correlated) with National American. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of National American has no effect on the direction of Integrated Biopharma i.e., Integrated Biopharma and National American go up and down completely randomly.
Pair Corralation between Integrated Biopharma and National American
If you would invest (100.00) in National American University on May 7, 2025 and sell it today you would earn a total of 100.00 from holding National American University or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Integrated Biopharma vs. National American University
Performance |
Timeline |
Integrated Biopharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
National American |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Integrated Biopharma and National American Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Integrated Biopharma and National American
The main advantage of trading using opposite Integrated Biopharma and National American positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Integrated Biopharma position performs unexpectedly, National American can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in National American will offset losses from the drop in National American's long position.Integrated Biopharma vs. Premier Foods Plc | Integrated Biopharma vs. Torque Lifestyle Brands | Integrated Biopharma vs. Aryzta AG PK | Integrated Biopharma vs. Calbee Inc |
National American vs. Sunlands Technology Group | National American vs. Perdoceo Education Corp | National American vs. Skillsoft Corp | National American vs. Coursera |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |